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The expression of myogenin is suppressed during innervation and has been implicated in determining properties of skeletal
muscle which are regulated by electrical activity. We previously reported that transcription driven by 3700 bp of the mouse
myogenin upstream sequence (MYG3700) is activated by denervation in transgenic mice (Nucleic Acids Res. 21, 5684±
5693, 1993). To extend our investigation of the activity dependence of the myogenin promoter, we have utilized myoblast
implantation as a novel approach to in vivo reporter analysis. Myoblasts for hindlimb injections were generated by stable
transfection of chloramphenicol acetyltransferase (CAT) reporters into a b-galactosidase-expressing line of C2 cells. In
vitro characterization of stable myoblast clones carrying myogenin±CAT deletion constructs revealed that while the
proximal myogenin 5*-¯anking sequence confers myotube speci®city, high-level expression requires a region upstream
(0335 to 01102) which depends on chromosomal integration for its function. For analysis by implantation, incorporation
of injected myoblasts into existing myo®bers was con®rmed by histochemical staining. Using clonal myoblasts harboring
nicotinic receptor a-subunit (a800) and myosin light chain reporters as positive and negative controls, respectively, for
denervation responsiveness, we determined that the nuclei of injected myoblasts are susceptible to regulatory signals
imposed by nerve-induced electrical activity of the myo®ber into which they incorporate. In in vivo analysis of myogenin
upstream sequence by implantation, CAT activities of MYG3700 and MYG1565 reporters in injected limbs increased up
to fourfold within 4 days after denervation, whereas the activities of MYG1102 and MYG335 were unchanged. By 10 days
after denervation, all myogenin reporters displayed denervation responsiveness. These implantation data suggest an early
phase of denervation activation, one that is mediated by control elements residing within 01102 to 01565 of the myogenin
upstream sequence. Thus, the combined analyses of stable reporter myoblast lines in vitro and in vivo by implantation
provide an ef®cient means of evaluating regulatory regions for high-level expression and neural modulation of muscle gene
transcription. q 1995 Academic Press, Inc.
INTRODUCTION and their messages is induced during muscle differentiation
to high levels throughout the embryonic myo®ber; upon
innervation, expression is suppressed and becomes re-Innervation is a central event in the maturation of skele-
stricted to the vicinity of the neural muscular junctiontal muscle. Nerve-induced electrical activity, in addition to
(Merlie and Sanes, 1985; Fontaine et al., 1988; Goldman andmodulating the expression of myo®brillar genes involved
Staple, 1989). Surgical denervation of adult skeletal musclein determination of ®ber type in vertebrates, also regulates
results in a dramatic reappearance of receptor subunits andgenes which determine sarcolemmal properties (Pette and
their mRNAs extrajunctionally, an effect which can be re-Vrbova, 1985; LoÈ mo and Gundersen, 1988). Of the latter
versed by stimulation with extracellular electrodes (Gold-category, the nicotinic acetylcholine receptor (nAChR) is a
man et al., 1988). Studies in transgenic mice utilizing pro-well-studied paradigm of neurally regulated skeletal muscle
moters of a (Merlie and Kornhauser, 1989; Klarsfeld et al.,genes (Hall and Sanes, 1993). Expression of nAChR subunits
1989), d (Simon et al., 1992), and e (Sanes et al., 1991) sub-
units con®rm that these innervation-dependent expression
patterns are determined at the level of transcription. Regula-1 To whom correspondence should be addressed at Building 49,
tion of nAChR subunit genes and other skeletal muscle-Room 5A-38, Unit of Molecular Neurobiology, Laboratory of De-
speci®c genes has become better understood since the dis-velopmental Neurobiology, National Institutes of Health, 9000
Rockville Pike, Bethesda, MD 20892. Fax: (301) 496-9939. covery of myogenic determination factors, a family of mus-
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cle-speci®c transcription factors which share homology We combined in vitro and in vivo approaches to deter-
mine how myogenin is regulated in terminally differenti-within the basic helix±loop±helix (bHLH) DNA-binding
and dimerization domain. Mammalian myogenic factors, ated muscle under the in¯uence of nerve-induced muscle
electrical activity. We analyzed DNA constructs consistingMyoD (Davis et al., 1987), myogenin (Wright et al., 1989;
Edmundson and Olson, 1989), MRF4 (Rhodes and Koniec- of deletion mutants of the 5*-¯anking region of the mouse
myogenin gene (Edmondson et al., 1992) fused to CAT cod-zny, 1989; Miner and Wold, 1990; Braun et al., 1990), and
Myf-5 (Braun et al., 1989), activate the transcription of a ing sequence. Characterization of myogenin reporters in
vitro using transient and stable transfections of culturedvariety of muscle-speci®c genes, including nAChR subunit
genes (Piette et al., 1990; Gilmour et al., 1991; Numberger cells revealed that a distal upstream region confers high-
level expression and requires integration into chromatin foret al., 1991; Prody and Merlie, 1992; Simon and Burden,
1993). The transcriptional control regions of nAChR sub- its function. To begin to examine in vivo the mechanisms
by which innervation controls myogenin gene expressionunit genes and many other muscle-speci®c genes have in
common one or more E boxes, the DNA sequence (5*-CAN- in mature muscle, we utilized the technique of myoblast
implantation (Partridge et al., 1989; Barr and Leiden, 1991;NTG-3*) through which the binding of myogenic regulators
mediates transactivation. Based on the ability to induce Dhawan et al., 1991). Cells of reporter myoblast lines were
implanted into the hindlimbs of adult mice and allowed tomyogenesis when introduced into nonmuscle cells in vitro,
it is accepted that the members of the MyoD family of incorporate into existing muscle ®bers. Reporter activities
of myogenin upstream deletions in innervated and dener-regulators are important players in commitment and differ-
entiation within muscle lineage (Olson, 1990). The role of vated limbs were then compared. With this method, we
identi®ed regions of myogenin upstream sequence likely tomyogenic factors later in development in establishing and
maintaining mature muscle phenotype, however, is not be involved in regulated expression in innervated muscle.
This is the ®rst report of analysis of muscle-speci®c promot-clear.
Indirect evidence has indicated that one or more myo- ers by myoblast implantation, the results of which compare
favorably with denervation studies of transgenic models.genic factors function in establishing mammalian gene ex-
pression patterns which are determined by innervation (Ef-
timie et al., 1991; Witzemann and Sakmann, 1991). MyoD,
myogenin, and Myf-5 messages, at high levels by birth, de- MATERIALS AND METHODS
crease to low levels throughout the postnatal period during
which the mature pattern of innervation is established. In CAT Reporter Constructs
contrast, MRF4 message accumulates perinatally. Denerva-
Myogenin±CAT reporter genes, derived from pCATbasiction of adult muscle results in rapid accumulation of myo-
(Promega), are essentially as previously described (Edmond-genin, MyoD, and MRF4 mRNAs, while the steady-state
son et al., 1992). Parental vector MYG3700 and exonucleaselevel of Myf-5 transcripts is relatively unaffected (Buonanno
III-generated MYG84 were kindly provided by E. Olson.et al., 1992). Quantitative time courses revealed that
Additional myogenin reporters MYG1565, MYG1102,changes in myogenin message levels precede changes in
MYG335, and MYG184 were created from MYG3700 bynAChR subunit expression during innervation and after de-
successive upstream deletions using convenient restrictionsnervation (Eftimie et al., 1991). Although many skeletal
sites (XbaI, SstI, SmaI, and PstI, respectively) to de®ne themuscle genes which contain functional E box elements are
5* ends. All myogenin sequences extend 3* to /18. Othernot repressed by nerve activity, eg., muscle creatine kinase
CAT reporters used in transfections are described else-(Lassar et al., 1989; Brennan and Olson, 1990) and myosin
where: a800 (chick nicotinic receptor a-subunit gene)light chain (Wentworth et al., 1991), denervation supersen-
(Klarsfeld et al., 1987), MLC (rat myosin light chain gene)sitivity of a d-subunit transgene was demonstrated to be
(Donoghue et al., 1988), and RSV (Rous sarcoma virus LTR)dependent on the presence of an E box (Tang et al., 1994).
(Gorman et al., 1982a). SV-40-driven pCATcontrol and pro-The correlation between changes in myogenin expression
moterless pCATbasic were obtained from Promega. Plas-and nAChR subunit expression suggests a direct causal link.
mids were prepared for transfection using Qiagen columnsHaving hypothesized that denervation activates the tran-
followed by cesium chloride gradient puri®cation.scription of nAChR genes through activation of the myo-
genin gene (Eftimie et al., 1991), we subsequently reported
that 3700 bp of myogenin 5*-¯anking sequence confers de- Transient Transfections
nervation sensitivity on chloramphenicol acetyltransferase
(CAT) reporter expression in transgenic mice (Buonanno et C2C12 cells were transiently transfected as myoblasts
using the calcium phosphate precipitation method (Grahamal., 1993). Thus, regulation of myogenin transcription may
be an early event in the same pathway through which nerve- and Van der Eb, 1973). Two independent preparations of
each plasmid were tested. Cells were plated at low densityinduced muscle activity controls expression of nAChR
genes in extrajunctional nuclei. We therefore focused on in growth medium (DMEM/20% FBS) for 18±24 hr before
transfection. Coprecipitates containing 10 mg of reportermyogenin as a potentially important locus of regulation by
neural activity. plasmid and 5 mg of internal control plasmid pSVbgal were
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applied to cells; cultures were subjected to glycerol shock on dry ice. Sections (20 mm) were ®xed on gelatin-coated
glass slides in 4% paraformaldehyde, 0.25% glutaraldehyde18±24 hr later. For assay as myoblasts, cultures were incu-
bated for an additional 24 hr in growth medium. For assay as for 5 min at room temperature, rinsed in PBS, and then
incubated overnight at room temperature in 2 mM 5-bromo-myotubes, cells were transferred to differentiation medium
(DMEM/5% FBS) for 48 hr. Transfected cells were harvested 4-chloro-3-indolyl-b-D-galactoside (X-Gal), 5 mM potas-
sium ferricyanide, 5 mM potassium ferrocyanide, 2 mMand extracted in 0.25 M Tris, pH 8, for determination of
CAT (Gorman et al., 1982b) and b-galactosidase (b-gal) MgCl2 in PBS. After X-Gal staining, slides were washed in
PBS, dehydrated in ethanol, and then counter-stained with(Nielsen et al., 1983) activities.
eosin. Following rinses in xylene, sections were mounted
in Permount (Fisher). For whole-mount preparations, intactStable Transfections
samples were ®xed in 4% paraformaldehyde, 0.25% gluter-
CAT reporters were cotransfected with a plasmid confer- aldehyde for 1 hr and then stained for b-gal activity over-
ring hygromycin resistance (pHyg) (Sugden et al., 1985) by night.
the calcium phosphate method. Each reporter was cotrans-
fected with pHyg at ratios by weight of both 5:1 and 10:1 in
independent transfections. Within 48 hr after transfection, RESULTS
cells were replated at low density in media supplemented
with 200 units/ml hygromycin (Sigma) and 200 mg/ml Ge-
Analysis of Myogenin 5* Flanking Sequence byneticin (Gibco). Colonies resistant to both hygromycin and
Transient Transfection of CAT Reporters in C2C12neomycin, apparent within 10 days, were chosen at random,
Cellsisolated, and replated for expansion as myoblasts. Platings
of early passages were screened as myotubes for CAT activ- We began deletion analysis of 3700 bp of myogenin up-
ity. Clones scored positive were further expanded under stream sequence by transient transfection of CAT reporters
selection for frozen stocks. into cells of the C2C12 murine myoblast line (Fig. 1). Sig-
ni®cant decrements in myotube-speci®c transcriptional ac-
tivity in the deletion analysis, up to threefold, were ob-Myoblast Implantations
served with loss of sequences between 03700 and 01102.
Implantations were carried out essentially as described Only reporters retaining 335 or more base pairs of myogenin
(Dhawan et al., 1991). Female C3H strain mice (Jackson upstream sequence displayed signi®cant developmental
Laboratories) were 4±6 weeks old at the time of myoblast speci®city of expression of CAT activity in cultured myo-
injection. Clonal myoblast populations were expanded as tubes. Expression in mouse myotubes may therefore require
needed from equivalent aliquots of frozen stocks. Cells har- the presence of the E box at 0308 to 0313. The E box at
vested by trypsinization were rinsed twice in ice-cold PBS 0136 to0141 does not bind in vitro synthesized myogenin±
and resuspended at a density of 2 1 108 cells/ml. Aliquots E12 and is not required for myotube-speci®c expression in
of 1 1 107 cells (50 ml) were each implanted through the primary chick cells (Edmondson et al., 1992). Activity of
skin at a total of three to ®ve sites into crural muscle using even the strongest myogenin reporter (MYG3700) was less
insulin syringes (28 1/2 gauge). Ten days later, one hindlimb than 10% of that obtained from transient expression of an
from each injected animal was denervated by surgical re- SV-40 promoter in the same parental vector (pCATcontrol).
moval of a 2- to 3-mm section of the sciatic nerve near the By comparison to activity of myotube-speci®c reporters for
hip. All injections and denervations were performed while other genes such as the nicotinic receptor a subunit (data
animals were anesthetized with Metofane (Pitman-Moore). not shown), we consider these results from transient trans-
Mice were sacri®ced by carbon dioxide asphyxiation 4 or fection of myogenin reporters to re¯ect relatively weak
10 days after denervation. Lower hindlimb muscles were transcriptional activity.
dissected, minced, and homogenized by sonication (2 1 10
sec) in 0.5 ml ice-cold 0.25 M Tris±HCl, pH 8.0, containing
protease inhibitors (0.5 mM PMSF, 1 mM leupeptin, 1 mM Stable Transfection of Myogenin±CAT Reporters
pepstatin A, and 0.3 mM aprotinin). Extracts, cleared by cen- Delineates an Integration-Dependent Activating
trifugation in a microfuge, were stored at 0207C until as- Sequence
sayed for reporter activity. Because the presence of variable
Large numbers of stable myoblast clones expressing CATamounts of hemoglobin in the extracts presented unaccept-
reporters were generated by transfection and selection inable background for a colorimetric assay, a ¯uorometric
hygromycin/neomycin-supplemented media. Because ofassay was used to measure b-gal activity as previously de-
their intended use for implantation experiments, clonesscribed (Dhawan et al., 1991; Roederer et al., 1991).
were generated from b-gal-expressing C2-Zc myoblasts (see
next section). Data from the screening of clones are summa-
Histochemical Staining rized in Table 1. For purposes of comparison, results ob-
tained from stable transfection of RSV, MLC, and a800 CATFor cryostatic sectioning, hindlimb muscle samples were
embedded in M-1 embedding matrix (Lipshaw) and frozen reporters are also given. Each construct was transfected
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myotubes derived from clonal lines expressing MYG3700,
MYG1565, and MYG1102 reporters expressed CAT activ-
ity at high levels compared to that in stably integrated
MLC and a800 reporters. CAT activity of deletion mu-
tants MYG335 and MYG184 in stable transfectants was
on average 30-fold less. Expression was virtually lost with
the MYG84 reporter. These results indicate that sequence
lying upstream of 0335 confers strong transcriptional ac-
tivation in myotubes. Deletion mutant MYG1102 is as
highly expressed as longer upstream constructs MYG3700
and MYG1565, such that sequence between 01102 and
0335 alone confers high-level expression on the myo-
genin promoter upon stable integration.
CAT activity of clonal cells expressing muscle-speci®c
reporters was 5- to 50-fold higher in myotubes than in myo-
blasts for equivalent amounts of protein extract (data not
shown). Populations of selected clones were expanded to
large numbers for myoblast implantation, and cells from
expanded clones were reassayed for reporter expression (Fig.
2). The presence of strongly activating elements residing
between 0335 and 01102 was not required for myotube-
speci®c transcription per se, since the weakly active
MYG335 reporter had at least 5 times higher expression in
myotubes than in myoblasts (Fig. 2).
Myoblast Implantation as a Means to Study
Transcriptional Regulation by Innervation
Our primary motivation for creating a large number of
stable reporter lines was for the purpose of myoblast im-
TABLE 1
Analysis of Myogenin Upstream Sequences in Stable CAT
Reporter Clones Delineates a Strong, Integration-Dependent
Activating Region between -335 and -1102
FIG. 1. Expression of CAT activity in C2C12 cells transiently Average CAT activity
transfected with myogenin±CAT reporters. Cells were transfected Cat construct Positive/total (range)
with the indicated reporter plasmids and assayed as described under
Materials and Methods. (A and B) Thin-layer chromatograms from RSV 8/16 3.47 (0.78 ±9.41)
representative transfections of cells harvested as myoblasts (MB) MLC 3/7 33.1 (1.83 ±76.8)
or myotubes (MT). (C) CAT activity normalized to b-gal activity a800 5/11 42.4 (1.36 ±95.6)
expressed relative to activity of SV-40-driven pCATcontrol in ei- MYG3700 8/12 26.8 (0.52 ±88.4)
ther myoblasts (gray bars) or myotubes (black bars). Data are means MYG1565 8/14 20.7 (2.19 ±64.4)
and SD of four independent experiments. MYG1102 8/16 30.4 (3.08 ±90.3)
MYG335 11/23 0.99 (0.11 ± 3.38)
MYG184 4/13 0.90 (0.59 ± 1.18)
MYG84 2/17 0.02 (0.021, 0.028)
with the hygromycin resistance marker at ratios of 5:1
The indicated reporter plasmids were stably transfected into C2-and 10:1 in independent transfections to ensure produc-
Zc cells in each of two independent transfections. Myoblast colo-tive integration events. Approximately equal proportions
nies were expanded and screened for CAT expression as culturedof antibiotic resistant colonies were picked at random
myotubes. Clones were scored positive if myotube expression offrom each transfection and analyzed for CAT activity. In
CAT activity was at least ®vefold over the assay background. Myo-
general, CAT activities for a given construct were distrib- tube activities of positive clones are reported as the mean and range
uted over a broad range, with approximately 50% of the of CAT activities standardized to the percentage conversion ob-
clones expressing the CAT reporter. We consider these tained from 10 mg of extract in a 1-hr assay at 377C; actual amounts
results to be evidence of having obtained a representative of extracts assayed were varied to obtain linearity of substrate con-
version.random sample of expressors for each construct. Positive
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FIG. 2. Myotube speci®city of CAT reporters expressed by stable clones. The indicated clones (see Table 1) were expanded further and
stored as frozen aliquots. Thaws of aliquots were assayed in vitro for CAT activity as myoblasts (gray bars) and myotubes (black bars).
CAT activity, here normalized to coexpressed b-gal activity, is given as the relative average obtained from two to three thaws for each
line. Average raw CAT conversions per 10 mg of extract per hour ranged from 1% (12C11 myoblasts) to 232% (1B2 myotubes). Data from
clones harboring the same CAT reporter are grouped, with the unique alphanumeric designation of each individual line indicated.
plantation with the goal of analyzing the mouse myogenin The C2-Zc myoblast line provided the parental cells into
which CAT reporters were stably introduced. Myoblasts ofupstream sequences in vivo. We felt that this approach
might prove useful in identifying control elements responsi- the C2-Zc clone, derived from C2 cells under neomycin
selection, are stable transfectants which express cyto-ble for the activation of transcription which likely accounts
for increased steady-state myogenin mRNA levels following plasmic b-gal under the control of a human globin promoter
and SV-40 enhancer (Ralston and Hall, 1989). b-gal activitymuscle denervation. Although there have been a few reports
of in vitro experiments using spontaneously active or elec- expressed by the clones provided a means to visualize im-
planted cells in injected tissue as well as an internal controltrically stimulated cultures of mammalian myotubes to an-
alyze activity regulation of reporters (Chahine et al., 1992; for variation in CAT assays of muscle extracts. The fate
of b-gal-expressing myoblasts was examined 14 days afterDutton et al., 1993), most studies have been performed in
transgenic mice. In one report (Bessereau et al., 1994), an injection by X-Gal staining (Fig. 3). The staining in injected
myoblasts is con®ned to differentiated muscle ®bers (Fig.in vivo analysis of a-subunit reporters was performed by
adenovirus infection of muscle. However, because this viral 3A). The staining patterns of cross sections (Figs. 3B±3D)
are typical of those obtained in general; penetration andvector remains extrachromosomal, the technique cannot be
used to address integration-dependent transcriptional incorporation of myoblasts into ®bers is widespread but
characteristically within a well-de®ned region of a muscleevents. We suspected that myoblast implantation would
prove faster and more ef®cient than transgenic mice as a group. Evident is the extent to which X-gal staining is con-
®ned to ®ber cross sections which are normal in appearance,way to study integrated reporters in innervated skeletal
muscle. Having gained notoriety for its usage in gene ther- with considerable variation of intensity between ®bers of a
given section. Staining of what appeared to be unincorpo-apy (Partridge et al., 1989; Barr and Leiden, 1991; Dhawan
et al., 1991), myoblast implantation as a means to study rated myoblasts was insigni®cant; no clusters of proliferat-
ing cells were apparent in the sections analyzed. Thus, im-muscle-speci®c reporters has not yet been demonstrated.
We therefore had two initial concerns with respect to study- planted cells remaining at the end of the experimental
period are incorporated into myo®bers. Furthermore, dener-ing innervation-regulated transcription. We wanted to be
sure that the technique resulted in an appropriate level of vation made no apparent difference in extent or pattern of
incorporation of myoblasts (Fig. 3).differentiation and incorporation of injected myoblasts into
existing myo®bers as previously reported (Morgan et al., Do nuclei from implanted myoblasts which have incorpo-
rated into myo®bers respond to the regulatory in¯uences1992; Hughes and Blau, 1992) and that the exogenously in-
troduced myo®brillar nuclei were susceptible to the regula- of the nerve? As a positive control, we used two independent
myoblast lines carrying a CAT reporter driven by the chicktory effects of nerve-induced muscle activity.
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FIG. 3. Expression of b-gal in muscle ®bers resulting from implantation of reporter myoblasts. Hind limbs of anesthetized C3H mice
were injected with b-gal-expressing clonal myoblasts. (A) whole-mount preparation of crural muscle injected with reporter myoblasts
showing intense X-gal staining of super®cial myo®bers. (B±D) cryostatic cross sections of myoblast-injected hindlimb muscle stained
with X-gal and counterstained with eosin. Samples in (A±D) were obtained from animals injected with MYG1102 reporter myoblasts
(clone 11D3). Images in (A and C) were derived from innervated muscle, whereas those in (B and D) were derived from 4-day-denervated
muscle. (A and B) magni®cation 140; (C) magni®cation 1160; (D) magni®cation 1320.
a-subunit promoter to examine this issue. The a800 re- Myogenin Upstream Sequence Confers
porter has been shown in transgenic mice to be up-regulated Transcriptional Activation by Denervation
transcriptionally by denervation, whereas the MLC se-
Myoblast clones carrying myogenin±CAT reporters werequence has been previously reported to be transcriptionally
tested by implantation into mouse hindlimb muscle. Theunresponsive to denervation in transgenic mice (see Merlie
CAT activity expressed from the MYG3700 reporter wasand Kornhauser, 1989). Using the technique of myoblast
three to four times greater in denervated limbs than in in-implantation, an average activation of the a800 reporter of
nervated limbs with 4-day denervation (Fig. 5). Results ofalmost fourfold can be demonstrated with denervation of
implantation experiments are comparable to those we ob-the injected limb (Fig. 4). In parallel implantation experi-
tained by testing the MYG3700 reporter in transgenic micements, MLC and RSV reporters are active in innervated
(Buonanno et al., 1993). The denervation response assayedmuscle and remain unaffected by denervation. Furthermore,
as CAT activity from implanted or transgenic limbs is con-b-gal activity assayed from the extracts did not vary with
siderably smaller than that measured at the level of endoge-denervation (Fig. 4D). The nonresponsive reporters not only
nous myogenin message. In studies of the MYG3700re¯ect appropriate regulation , but also provide controls for
transgene, however, we have determined that CAT mRNApossible nonspeci®c or secondary effects of muscle denerva-
does increase with denervation to the same extent as thetion, such as proliferation of mononucleated cells (Murray
endogenous message (Buonanno et al., 1993). The greaterand Robbins, 1982). Thus, the response of a800 reporter
stability of CAT protein relative to CAT mRNA may belines to denervation is speci®c and is consistent with results
obtained in transgenic mice. responsible for diminishing or delaying innervation-induced
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down-regulation of CAT activity, resulting in high baseline
expression of enzyme activity in innervated muscle. Be-
cause of this limitation of CAT reporter analysis, some role
for mRNA stability in the regulation of expression of myo-
genin by innervation and denervation is not ruled out.
The MYG1565 reporter in implanted cells was also acti-
vated by denervation; for the three clones tested, mean rela-
tive activation by denervation varied from 1.5- to 3-fold
(Fig.5). In contrast, none of the ®ve clones harboring
MYG1102 and MYG335 which were implanted showed any
signi®cant differences in CAT activity between innervated
and 4-day-denervated limbs. Despite the low CAT activity of
the MYG335 reporter compared to longer constructs, activity
from injected muscles could be readily measured from 20%
or less of the total extract in a standard 1-hr assay. We did
®nd that by 10 days after denervation, all the myogenin±
CAT reporters tested were activated 2-fold or more by dener-
vation (Fig. 6), qualitatively consistent with a recent
transgenic analysis of these constructs using 10-day denerva-
tion (Merlie et al., 1994). Our comparative analysis of the
myogenin±CAT reporters in 4-day versus 10-day denervated
muscle indicates that the presence of approximately 450 bp
of sequence (01102 to 01565) may confer an early phase of
denervation responsiveness in implanted myoblasts. Exami-
nation of this region for consensus sequences reveals several
potential sites for transcription factor binding. The signi®-
cance of some of these sites with regard to transcriptional
activation by denervation is addressed below.
DISCUSSION
Regions of Myogenin 5*-Flanking Sequence
Important for Transcription in Terminally
Differentiated Muscle
Our ultimate aim is to understand how nuclear factors which
are intimately involved in determination and differentiation of
skeletal muscle might, later in development, play a role in
phenotypic modulation of the differentiated state. Myogenin
transcription is induced by differentiation of cultured myo-
blasts into myotubes (Edmondson and Olson, 1989; Wright et
FIG. 4. Denervation selectively activates transcription of a800
al., 1989). Factors responsible for activating myogenin transcrip-reporter in implanted muscle cells. Clonal myoblasts harboring
tion during differentiation might be good candidates for media-RSV, MLC, or a800 CAT reporters were injected into the hindlimbs
tors of activation by denervation in mature muscle. We prelimi-of C3H mice and tested for reporter activity in innervated and 4-
narily tested myogenin±CAT reporters in vitro by transfectionday-denervated muscles. (A) Representative thin layer chromatog-
of C2C12 murine myoblasts. Analysis of myogenin±CAT re-raphy of CAT assay of samples obtained from innervated (I) and dener-
vated (D) limbs from individual mice injected with the indicated porters by stable transfection revealed that sequence between
clonal myoblasts. (B±D) Gray bars are data from innervated limbs and 0335 and 01102 strongly activates transcription. This region
black bars are data from denervated limbs. (B) Mean percentage confers little or no enhancement of reporter activity when tran-
conversions of CAT assays for injected limbs grouped by myoblast
clone. (C) Data relative to innervated limbs for each individual
clone. (D) Relative mean b-gal activities coexpressed in injected
muscle, with the total number of animals assayed for each reporter
clone indicated. CAT activities represented (A and B) were normal- CAT activity was varied to remain in the linear range of the assay.
ized to an arbitrary b-gal activity value of 60 units (approximately Error bars are SEM. The n value for each group is given above the
2% of the average total extracted from a single injected limb). The data bars in C. Asterisks, signi®cantly different from innervated
actual amount of extract used for quantitative determination of limb (unpaired t test, P  0.05).
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(LCR), as described for the globin gene cluster (Felsenfeld, 1992).
A distal activating region of the mouse MyoD gene, thought to
be active in both C2C12 myoblasts and myotubes, also requires
integration for function (Tapscott et al., 1992). In addition to E
boxes (0372 to 0377,0770 to0775, and 01083 to 01088) and
an Sp1 consensus site (0955 to 0961) in this region, there is a
[CA]22 repeat sequence (0560 to 0603). Alternating purine±
pyrimidine tracts have the potential to form Z-DNA in vitro
and have been implicated in mediating transcriptional regula-
tory effects in chromatin (Nordheim and Rich, 1983; Kladde et
al., 1993).
The distal activating region itself may not confer any
developmental speci®city on proximal promoter function,
since the region appears to increase both myoblast and myo-
tube expression in stable clones. Although one or more of
the three putative E boxes within the region could confer
high-level expression in myotubes, it appears that the region
may function constitutively. This possibility is also sup-
ported by the ®nding that sequence between 0134 and
01102 drives high-level expression of a heat shock pro-
moter±lacZ fusion gene that is not muscle-speci®c in
transgenic embryos (Yee and Rigby, 1993). Tissue speci®c-
ity of expression likely resides in more proximal sequence.
Our transfection analysis indicates that while promoter-
proximal sequence to 084 is insuf®cient to confer myotube
speci®city on transient expression in C2 cells, inclusion
of sequence between 084 and 0335 speci®cally enhances
reporter expression in differentiated cells. While a MEF-2
site (058 to 066) appears to be necessary for expression in
both cultured cells (Edmondson et al., 1992) and transgenic
embryos (Yee and Rigby, 1993; Cheng et al., 1993), the role
of the three promoter-proximal E boxes (010 to 015, 0136
to0141, and0308 to0313) is not clear. Transgenic analyses
suggest they may be redundant in major aspects of their
function (Cheng et al., 1992; Yee and Rigby, 1993). A com-
plete analysis of proximal E boxes may require testing in
FIG. 5. Upstream sequence activates the myogenin promoter in
response to 4-day denervation. (A) CAT activity normalized to
coexpressed b-gal activity. (B) Data relative to innervated limbs for
each reporter clone. (C) Data relative to coexpressed b-gal activity.
Data reported are normalized as in Fig. 4 and reported as mean
values and SEM for innervated limbs (gray bars) and denervated
limbs (black bars). The n value for each group is given above the
data bars in C. Asterisks, signi®cantly different from the innervated
limb (unpaired t test, P  0.05).
FIG. 6. Ten-day denervation reveals a late phase of transcriptional
siently expressed in C2C12 cells (this study) or in chick myo- activation. Activity of CAT reporters (mean and SEM) in innervated
tubes (Edmondson et al., 1992). Although not formally demon- (gray) and denervated (black) limbs, normalized as in Fig. 4C. The
strated,this region displays the characteristics of an integration- n value for each group is given above the data bars. Asterisk, sig-
dependent enhancer. The requirement of chromosomal integra- ni®cantly different from the innervated limb (unpaired t test, P 
0.05).tion for activation is a de®ning trait of a locus control region
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the context of the distal activating region identi®ed in this tion has been shown to increase both fos and jun expression
in differentiated muscle, with fos mRNA reaching maximalstudy. It is evident from our data that such an analysis
should be carried out on stably integrated reporters. levels within 3 hr after denervation (Bessereau et al., 1990).
Increased levels of fos and jun proteins in denervated mus-
cle have also been reported (Weis, 1994). We propose that
Distinct Regions of Upstream Sequence Confer further analysis of the more distal sequence of myogenin
Activation on the Myogenin Promoter in Response upstream (0335 to 01565) will be important to understand-
to Denervation ing the regulation of myogenin expression in differentiating
and maturing skeletal muscle.Analysis of the mouse myogenin gene by myoblast
implantation revealed early activation MYG3700 and By using myoblast implantation to identify regions of the
myogenin 5*-¯anking sequence which function to regulateMYG1565 reporters in denervated muscle. These results are
qualitatively comparable to those obtained by transgenic promoter activity in mature innervated skeletal muscle, we
have demonstrated that the technique can provide an ef®-analyses and improve upon the sensitivity afforded by direct
injection of DNA into skeletal muscle (Wolff et al., 1990) cient means to analyze muscle-speci®c transcriptional regu-
lation in vivo. The use of stable myoblast lines for injectionby at least 20-fold (A.B., unpublished observation). Clonal
cells carrying the MYG1102 reporter have high levels of represents an experimental compromise between the conve-
nience of in vitro approaches and the power of transgenicCAT activity in cultured myotubes, but display little or no
enhancement of transcription in 4-day-denervated muscle. analysis. An obvious advantage of the technique is that it
allows for parallel in vitro and in vivo analyses of an inte-The MYG335 reporter, like the MYG1102 reporter, shows
no sensitivity to 4-day denervation in the implantation grated reporter. Minimally, promoter analysis by myoblast
implantation can provide preliminary screening of muscleassay. However, by 10 days following denervation, both re-
porters display a denervation response. Therefore, a delayed gene constructs prior to introduction as transgenes. We are
currently adapting myoblast injection to analyze ®ber typeresponse to denervation was observed when constructs
which lack the 01102 to 01565 upstream sequence were speci®city of gene expression. That myoblast implantation
can be modi®ed to suit speci®c applications underscores itstested by implantation. Interestingly, Merlie et al. (1994)
have reported a mixed response to 10-day denervation by potential as a powerful gene transfer technique with which
to study muscle development.MYG335 and mutant MYG335(-E1) CAT constructs in
transgenic mice. These reporters are unresponsive to dener-
vation in soleus muscle. However, the transgenes do display
denervation sensitivity in tibialis and EDL muscles. The ACKNOWLEDGMENTS
response of the MYG335 constructs in fast muscle groups
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proteins, which are detectable immunohistochemically by
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